| Eileen Haley, SLP | |
|
4705 Morgan Dr, Chevy Chase, MD 20815 | |
| (301) 272-5685 | |
| Not Available |
| Full Name | Eileen Haley |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4705 Morgan Dr, Chevy Chase, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528327392 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 02767 (Maryland) | Primary |
| 235Z00000X | Speech-language Pathologist | SLP000024 (District Of Columbia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Eileen Haley, SLP 4705 Morgan Dr, Chevy Chase, MD 20815 Ph: (301) 272-5685 | Eileen Haley, SLP 4705 Morgan Dr, Chevy Chase, MD 20815 Ph: (301) 272-5685 |
News Archive
Mallinckrodt plc, a leading specialty biopharmaceutical company, announced today that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million.
Genzyme Corp. has signed a consent decree agreeing to correct manufacturing quality violations at its Allston, Mass., manufacturing facility and will turn over to the federal government $175 million in unlawful profits from the sale of products that were made at the plant, the U.S. Food and Drug Administration announced today.
The Endocrine Society today announced it has chosen 13 leading endocrinologists as winners of its prestigious 2019 Laureate Awards, the top honors in the field.
Bristol-Myers Squibb Canada is pleased to announce that the Ontario government has made ERBITUX(TM) (cetuximab) available to patients suffering from metastatic colorectal cancer. This decision makes Ontario the second province, after British Columbia, to introduce funding for this important treatment option and represents encouraging news for those patients who rely on provincial drug coverage and stopped responding to standard treatments for metastatic colon cancer.
Research supported by the Autism Speaks Autism Treatment Network (ATN), demonstrating that symptoms of attention deficit and hyperactivity worsen quality of life for individuals with autism spectrum disorders (ASD), was presented today at the Society for Developmental & Behavioral Pediatrics Annual Meeting in San Antonio, Texas.
› Verified 2 days ago
Lauren Mary La Bella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin Ave Ste 1135, Chevy Chase, MD 20815 Phone: 301-654-1666 | |
Emily Duke Wishik, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin Ave, Suite 1135, Chevy Chase, MD 20815 Phone: 301-654-1666 Fax: 301-654-7175 | |
Mrs. Susan T. Billington, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3306 Cummings Ln, Chevy Chase, MD 20815 Phone: 301-915-0379 | |
Kerry Corso, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin Ave, Suite 1528, Chevy Chase, MD 20815 Phone: 301-654-1666 Fax: 301-654-7175 | |
Brooke Goldstein, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin Ave Ste 1135, Chevy Chase, MD 20815 Phone: 301-654-1666 | |
Julia Marie Cawkell Docking, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7001 Brookville Rd, Chevy Chase, MD 20815 Phone: 301-512-7453 | |
Juventino Aceves, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin, Chevy Chase, MD 20815 Phone: 301-654-1666 |